It is critically important that advances in AI technology are included in the screening procedure for DEDs to support our goal of improving access to care for underserved and at-risk populations. Technology can help to improve the accuracy and efficiency of the screening process for all DEDs, especially diabetes-related retinopathy which affects 463 million people worldwide . Improvements in screening technology will also benefit ophthalmologists and retinal specialists by reducing their workload and ensuring patients get quick and reliable diagnoses so as to best manage their condition.
The infographic below  represents the huge ratio of people with diabetes-related retinopathy and an ophthalmologist, highlighting an urgent need to improve the current screening strategy. This can be achieved through inclusion of advanced AI technology to help ophthalmologists help their patients.